H.R. 1717, The Medicare DMEPOS Market Pricing Program Act of 2013, has been introduced to the House thanks to the bipartisan efforts of Rep. Tom Price, M.D. (R-Ga.) and Rep. John Larson (D-Conn.) The two Congressmen, senior members of the House Ways and Means Committee.
H.R. 1717 will stop the bidding program, forcing CMS to adopt a market-based approach to determine prices for home medical equipment that is prescribed by doctors for Medicare patients rather than relying on administrative price setting.
The bidding program, which has drawn scathing criticism from more than 240 economists, including five Nobel laureates, patient advocacy groups, and companies that provide home medical equipment through Medicare, had been set to roll out to 91 additional areas across the country on July 1. It was piloted in nine areas beginning in early 2011.
Learn more about the Market Pricing Program alternative to CMS' ill-conceived bidding program.